Zhijiang Biotech: Third Quarter Report 2024

SZSIOct 30 00:00 · Announcements

Zhijiang Biology (688317.SH) plans to distribute 0.11 yuan per share and pay dividends on October 18th.

Zhijiang Biological (688317.SH) announced that the company's 2024 interim equity distribution plan: cash dividend per share...

Zhitong FinanceOct 10 16:56

Zhijiang Biotechnology (688317.SH): The relevant biotechnology bills in the USA have not involved the company.

Zhejiang Biotechnology (688317.SH) stated on the interactive platform on September 18th that the relevant biotechnology legislation in the United States has not involved our company and has no direct impact. The company's main business is running normally and steadily. The company will closely monitor this matter.

Gelonghui FinanceSep 18 16:11

Zhijiang Biology (688317.SH): has obtained the monkeypox product EU CE and UK MHRA certification.

On September 2, GeLongHui reported that ZhiJiang Biology (688317.SH) stated on the interactive platform that the company has obtained EU CE and United Kingdom MHRA certification for smallpox products, allowing sales in EU countries, the United Kingdom, and countries with relevant certifications. The company will continue to closely monitor the development of smallpox-related epidemics in overseas markets.

Gelonghui FinanceSep 2 15:32

Zhijiang Biotech: 2024 Semi-Annual Report

SZSIAug 29 00:00 · Announcements

Zhijiang Biotech: 2024 Semi-Annual Report Summary

SZSIAug 29 00:00 · Announcements